The organizational set up of various functionaries in Drugs and Control Administration are broadly classified into two wings.

    1. Enforcement Wing 2. Laboratory Wing.

    Enforcement Wing performs the functions of enforcement of the above legislations in the State and Laboratory Wing performs the Test/Analysis of various Drugs/Cosmetics samples sent for analysis and issues the Certificate of Test/Analysis.

    In 1976, FDA was carved out from the Directorate of Medical and Health, headed by an IPS Officer till 1981. Drugs Control Administration, A.P was separated from the office of the Drugs Controller & State Food Health Authority in the year 1981 and was made an independent Department headed by Director, DCA till 1996.

    In Aug 1996, Govt. had posted an IPS officer of the rank of Inspector General of Police, Drugs and Copyright to head the DCA. Subsequently this post was upgraded to ADGP/DGP level as the HOD.

    After the bifurcation of erstwhile Andhra Pradesh state, the Drugs Control Administration department of Telangana State was setup on 02.06.2014.

  • Hand Sanitizers - Requirements to be met by the applicant firms

  • Circular issued to Industrial Oxygen Manufacturers in Telangana regarding granting of permissions to ensure adequate supply and availability of Medical Oxygen in view of COVID-19

  • Advisory for maintaining safe and adequate blood supply during the pandemic outbreak of COVID-19 issued to Blood Banks in Telangana State

  • Visit HOW TO APPLY tab of main menu for Checklists of Applications, fees structure and proforma
    Details of the drugs declared as Not of Standard Quality NSQ by Drugs Control Laboratory, Telangana are published at -Public Services - NSQ drugs of Home Page
  • Drug Alert - Infant Mortalities reported - Coldbest PC Syrup, B. No. DL5201, Mfd. 09 2019, Exp. 08 2021 Mfd. By. Digital Vision, Sirmour Himachal Pradesh - Diethylene Glycol found

  • Notice regarding List of Reference Products for conduct of BE Study for Oral Solid Dosage Forms containing BCS Class II and Class IV drugs

  • Applications regarding Medical Devices, IVDs of Risk Class A and B have to be made through CDSCO portal
  • Condition of licence for undertaking on brand or trade names of drugs under Drugs and Cosmetics Rules, 1945

  • Advisory by the DCGI regarding Rational use of Antibiotics for limiting Antimicrobial resistance

  • Guidance regarding uploading of manufacturing site and formulations data on SUGAM Portal

  • Procedure to the followed for subsequent applicant in respect of FDCs declared as rational by Prof. Kokate Committee and approved by DCGI

  • DCGI Circular regarding submission of Stability Data along with application for grant of licence for drugs

  • Constitution of State Level Committee to determine the quantum of compensation in respect of faulty ASR Hip Implants.

  • Guideline issued by CDSCO for uploading manufacturing sites and formulation data on the SUGAM Portal by manufacturers

  • Applications for Grant of NOC and Manufacturing Licence for Specific Quantity Exports shall be processed by DCA as a Single Application w.e.f. 20-08-2018
  • Circular issued regarding certain instructions on sale of Oxytocin

  • Applications for Grant and Renewal of Licences of Blood Banks shall be accepted vide online through ODLS portal only from 13th August 2018
  • GO issued regarding amendment of Maximum Response Time for online application process for Grant of licenses and Omission of Renewal of Licences from GO Ms No 103 dated 21-06-2017

  • G.O. issued by Government of Telangana regarding fixation of Time limits for the services provided under Online Drug Licensing System through TS-iPASS under EoDB

  • GO issued regarding Online Application process for Issue or Renewal of Licenses Ease of Doing Business 2017

  • COVID - 19

    Main Menu

    Public Services

      Your are Visitor #201704